|Articles|September 1, 2010
- BioPharm International-09-01-2010
- Volume 23
- Issue 9
BioPharm International, September 2010 Issue (PDF)
Combine Mechanistic Modeling and DoE to Streamline QbD
Advertisement
Articles in this issue
over 15 years ago
REMS Program Challenges Manufacturers, Providersover 15 years ago
Quality Management Systems for Small Biopharmaceutical Organizationsover 15 years ago
Biosimilars Approvals in the US: The Path Forwardover 15 years ago
Biosimilars, Part 3: Interchangeabilityover 15 years ago
Build Versus Buy in the Current Biotech Market EnvironmentNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Implementing Automation and Flexible Design for Allogeneic Manufacturing
2
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
3
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
4
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
5
